<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0567439" disease_type="Disease or Syndrome" abbrv="">Genetic syndromes</z:e> including <z:hpo ids='HP_0002671'>basal cell nevus</z:hpo> syndrome (BSNS), <z:e sem="disease" ids="C0043346" disease_type="Neoplastic Process" abbrv="">xeroderma pigmentosum</z:e> (XP), and <z:e sem="disease" ids="C0014522" disease_type="Neoplastic Process" abbrv="EV|EVER">epidermodysplasia verruciformis</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">EV</z:e>) predispose the individual to <z:e sem="disease" ids="C0007114" disease_type="Neoplastic Process" abbrv="">skin cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0002671'>Basal cell carcinomas</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BCCs</z:e>) often develop in patients with BCNS and XP </plain></SENT>
<SENT sid="2" pm="."><plain>One of the aims of surveillance examination in these patients is to detect <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BCC</z:e> while the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> are still small and easy to manage </plain></SENT>
<SENT sid="3" pm="."><plain>Dermoscopy, by allowing the visualization of arborizing vessels, ovoid nests, nonaggregated blue-gray globules, and spoke-wheel and leaf-like structures, can facilitate in the early detection of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BCC</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Patients with XP are also at risk for developing <z:hpo ids='HP_0002860'>squamous cell carcinoma</z:hpo> (<z:mp ids='MP_0004207'>SCC</z:mp>) </plain></SENT>
<SENT sid="5" pm="."><plain>Dermoscopy can assist in the early detection of these <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> by allowing the observer to visualize focal glomerular vessels, which is a common feature seen in <z:mp ids='MP_0004207'>SCC</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain>This feature can also assist in detecting <z:mp ids='MP_0004207'>SCC</z:mp> developing in other syndromes such as <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">EV</z:e> and <z:e sem="disease" ids="C0014527" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">epidermolysis bullosa</z:e> (EB) </plain></SENT>
<SENT sid="7" pm="."><plain>In addition to helping in the detection of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BCC</z:e> and <z:mp ids='MP_0004207'>SCC</z:mp>, dermoscopy can also help detect <z:hpo ids='HP_0002861'>melanoma</z:hpo> in individuals with XP and evaluate <z:e sem="disease" ids="C0027960" disease_type="Neoplastic Process" abbrv="">nevi</z:e> developing in those with EB </plain></SENT>
<SENT sid="8" pm="."><plain>This review will discuss how dermoscopy can be used in the management of patients with BSNS, XP, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">EV</z:e>, and EB and will discuss the dermoscopic findings of vascular lesions, including <z:mpath ids='MPATH_628'>pyogenic granuloma</z:mpath>, <z:hpo ids='HP_0001028'>hemangioma</z:hpo>, <z:hpo ids='HP_0001052'>port-wine stain</z:hpo>, and <z:hpo ids='HP_0100764'>lymphangioma</z:hpo> circumscriptum </plain></SENT>
</text></document>